Document Detail

Anticonvulsants and breast feeding: a critical review.
MedLine Citation:
PMID:  10937463     Owner:  NLM     Status:  MEDLINE    
Progress in the diagnosis and management of seizure disorders and the availability of effective anticonvulsive medications has enabled increasing numbers of epileptic women of child-bearing age to raise families. Breast feeding, which these women may wish to choose, provides health, nutritional, immunological, developmental, social, economic and environmental benefits. The traditional anticonvulsants, such as phenytoin, carbamazepine and valproic acid (valproate sodium), are generally considered safe for use during breast feeding; however, observation for adverse effects is recommended. The use of phenobarbital while breast feeding is controversial because of its slow elimination by the nursing infant. The newer anticonvulsants, such as clobazam, felbamate, gabapentin, lamotrigine, oxcarbazepine, tiagabine, topiramate, and vigabatrin, are used mainly as adjunctive therapy. Data on the use of these drugs in pregnancy and lactation, and regarding long term effects on cognition and behaviour, are sparse. Weighing the benefits of breast feeding against the potential risk to the nursing infant, breast feeding is considered to be safe when the mother is taking carbamazepine, valproic acid or phenytoin. Infant monitoring for potential adverse effects is advisable when the mother is taking phenobarbital, clobazam, gabapentin, lamotrigine, oxcarbazepine or vigabatrin. Monitoring of infant serum drug concentrations is advisable but not compulsory. The use of felbamate, tiagabine and topiramate during breast feeding should await further study.
B Bar-Oz; I Nulman; G Koren; S Ito
Related Documents :
3977283 - Infant feeding and growth--a longitudinal study in three swedish communities.
8684733 - Infant weaning practises of some idoma women in makurdi, nigeria.
3884243 - Detection of clostridium botulinum type b toxin in the presence of a lethal substance i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Paediatric drugs     Volume:  2     ISSN:  1174-5878     ISO Abbreviation:  Paediatr Drugs     Publication Date:    2000 Mar-Apr
Date Detail:
Created Date:  2000-08-29     Completed Date:  2000-08-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  100883685     Medline TA:  Paediatr Drugs     Country:  NEW ZEALAND    
Other Details:
Languages:  eng     Pagination:  113-26     Citation Subset:  IM    
The Department of Neonatology, Hadassah Medical Center, Jerusalem, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticonvulsants / adverse effects*,  metabolism,  therapeutic use
Breast Feeding / adverse effects*
Infant, Newborn
Milk, Human / metabolism
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recognising antibacterial hypersensitivity in children.
Next Document:  Respiratory syncytial virus immunoprophylaxis: impact on epidemiology.